Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Clinical implications of FLT3 mutations in pediatric AML.

Meshinchi S, Alonzo TA, Stirewalt DL, Zwaan M, Zimmerman M, Reinhardt D, Kaspers GJ, Heerema NA, Gerbing R, Lange BJ, Radich JP.

Blood. 2006 Dec 1;108(12):3654-61. Epub 2006 Aug 15.

2.

Prognostic significance of FLT3-ITD in pediatric acute myeloid leukemia: a meta-analysis of cohort studies.

Wu X, Feng X, Zhao X, Ma F, Liu N, Guo H, Li C, Du H, Zhang B.

Mol Cell Biochem. 2016 Sep;420(1-2):121-8. doi: 10.1007/s11010-016-2775-1. Epub 2016 Jul 20. Review.

PMID:
27435859
3.

Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.

Port M, Böttcher M, Thol F, Ganser A, Schlenk R, Wasem J, Neumann A, Pouryamout L.

Ann Hematol. 2014 Aug;93(8):1279-86. doi: 10.1007/s00277-014-2072-6. Epub 2014 May 7. Review.

PMID:
24801015

Supplemental Content

Support Center